Developer docs
API playgroundTry for free, no card

Search company profiles

The Geneva Foundation

Full company profile

uuid0009ze6

Namestring
The Geneva Foundation
Legal namestring
The Geneva Foundation
Websiteurl
genevausa.org
Company typeenum
Private
Founded yearint
1993
Descriptiontext

The Geneva Foundation is a 501(c)(3) nonprofit research organization founded in 1993 and headquartered in Tacoma, Washington, with operational offices in Bethesda, Maryland; Frederick, Maryland; and Fayetteville, North Carolina. The organization provides research administration, regulatory affairs, program management, staffing, and contracting services to support military-relevant medical research across 39 DoD installations, federal laboratories, and academic partner institutions worldwide. Geneva is a statutory nonprofit authorized under the FY2014 National Defense Authorization Act to facilitate partnerships between military investigators and public or private organizations, with the unique ability to proffer or gift intellectual property to the Federal government.

Geneva's core operational model consists of four major research programs: AREVA (wearable life support and trauma technologies), MIRROR (musculoskeletal injury research with 40+ active studies), REC3ON (combat casualty care research), and the USU-4D Bio3 Center for Biotechnology (bioprinting, organ-on-chip, on-demand blood). The organization manages $387M in annual grant funding flowing to Geneva-supported principal investigators and secured over $45M in direct funding in 2024. Geneva partners with 250+ sponsors and collaborators including federal agencies (DoD, NIH, HHS, VA, CDMRP, DARPA, BARDA), academic institutions (Johns Hopkins, Stanford, MIT, Mayo Clinic, Thomas Jefferson), and industry players (Mapp Biopharmaceutical, Island Pharmaceuticals, Maquet Getinge, Fresenius).

Geneva generates revenue through federal research grants and contracts, industry-sponsored clinical trial management, GSA Schedule government contracting services, and donor philanthropy via the Discovery Fund. The organization operates on a break-even nonprofit basis with no profit assessed on grant awards; indirect cost rates are authorized by the Office of Naval Research. Customer concentration is overwhelmingly federal, with the U.S. Department of Defense and Military Health System as the primary client base. Distribution is achieved through embedded personnel at military treatment facilities and federal labs, with the H2F System teaming contract (awarded to Serco Inc. at $247M) representing a major recent commercial channel.

Short descriptiontext

The Geneva Foundation is a 501(c)(3) nonprofit research organization that provides research administration, program management, and contracting services to advance military medical research across 39 DoD installations and federal laboratories, partnering with 250+ government, academic, and industry sponsors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersTacoma, United States
HQ citystring
Tacoma
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
military medical research, clinical trial administration, federal research contracting, biodefense research, combat casualty care
Industry4 codes
1Defense R&D, Test, Evaluation & Innovation
CodeBPAIAHACPrimaryYes
2Global Health Research, Clinical Trials & Product Development Partnerships (PDPs)
CodeHLAJAOAMPrimaryNo
3Research & Science Grantmaking Foundations
CodeBPAGAKAIPrimaryNo
4Global Health Research, Evidence & Technical Assistance Organizations
CodeHLAJAKANPrimaryNo
NAICS code4 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715
  • Medical Laboratories621511
SIC code4 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
  • Biological Products, (No Disgnostic Substances)2836
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Military medical research administration
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Federal Research Grants and Contracts
TypeSubscription Recurring
Description

Geneva secures and manages federal awards from DoD, NIH, HHS, VA, CDMRP, and other agencies. The organization recovers award management expenses through approved indirect cost rates authorized by the Office of Naval Research. Geneva operates on a break-even basis without assessing fees or profit on grant awards.

genevausa.org
2Industry Sponsorship and Clinical Trial Management
TypeProfessional Services
Description

Geneva acts as intermediary between industry sponsors and military physicians, facilitating clinical trials. Military physicians cannot contractually obligate or receive direct payment for clinical trials, so Geneva submits research proposals on their behalf and collaborates with sponsors on agreement terms. Geneva recruits and manages dedicated study coordinators, regulatory specialists, and contract personnel.

genevausa.org
3Government Contracting
TypeManaged Services
Description

Geneva holds a GSA Schedule under the Multiple Award Schedule (MAS), streamlining federal customer service delivery. Services include staffing, program management, regulatory affairs, and research operations support for federal agencies.

genevausa.org
4Philanthropy and Donor Contributions
TypeSubscription Recurring
Description

Geneva accepts tax-deductible donations as a 501(c)(3) nonprofit. Donors can contribute to the Discovery Fund to support follow-on research, pilot studies, new researcher empowerment, and urgent challenges.

genevausa.org
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 6 records shown
1AREVA (Autonomous Reanimation and Evacuation Research Institute & Innovation Center)
Description

Program advancing wearable medical technologies, polytrauma management, and critical care solutions tailored to combat and austere environments.

genevausa.org
+5 more records
Core offering1 text field

The Geneva Foundation is a 501(c)(3) nonprofit research organization that administers and manages military medical research on behalf of DoD investigators and federal agencies. It secures and manages federal grants and contracts from DoD, NIH, HHS, VA, and CDMRP; facilitates industry-sponsored clinical trials by acting as the contractual intermediary for military physicians; and deploys dedicated research personnel across 39 DoD installations and federal laboratories. Its program portfolio includes AREVA (critical care/portable ECMO), MIRROR (musculoskeletal injury research), REC3ON (combat casualty care), and the USU-4D Bio3 Center for Biotechnology.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • More than 400 research programs supported across military treatment facilities, federal laboratories, and academic institutions worldwide
+5 more records
Product overview1 text field

The Geneva Foundation is a nonprofit research organization that advances military medical research through multiple specialized programs and service offerings. The core portfolio includes AREVA (critical care and extracorporeal life support technologies), MIRROR (musculoskeletal injury rehabilitation research), REC3ON (combat casualty care research), and the USU-4D Bio3 Center for Biotechnology (bioprinting and advanced biotech). These programs are supported by foundational services including research administration, regulatory affairs, government contracting, data management, staffing, education and training, commercialization support, and research dissemination. The organization operates as a strategic convener connecting government, academia, industry, and research teams to deliver mission-ready medical solutions.

Product and service9 records
1AREVA (Autonomous Reanimation and Evacuation Research Institute & Innovation Center)
CategoryResearch Program
Description

Research program advancing wearable medical technologies, polytrauma management, and critical care solutions tailored to combat and austere environments; develops portable extracorporeal life support (ECLS/ECMO) systems, heparin-free systems, and autonomous critical care technologies. For military investigators, federal agencies, and industry collaborators.

2MIRROR (Musculoskeletal Injury Rehabilitation Research for Operational Readiness)
CategoryResearch Program
Description

Research program providing critical infrastructure and operational support for transforming treatment and preventive care of musculoskeletal injuries (MSKI) within the Military Health System, managing over 40 studies. For military investigators and federal agencies.

3REC3ON (Research for Combat Casualty Care Operations Network)
CategoryResearch Program
Description

Research program advancing combat casualty care through research in hemorrhage control, battlefield resuscitation, and innovative treatment technologies. Based at Madigan Army Medical Center with active duty, reservist, and staff surgeons. For military investigators and federal agencies.

4USU-4D Bio3 Center for Biotechnology
CategoryResearch Program
Description

Center developing and adapting biotechnology to benefit warfighter readiness and resilience; focuses on biofabrication, tissue engineering, organ-on-chip, on-demand blood production, and bioprinting for austere military environments. For military investigators and federal agencies.

5Fort Liberty Research Institute
CategoryResearch Program
Description

Research institute conducting mission-focused research in human performance, sustainment, and traumatic brain injury to support warfighter readiness and resilience. For military investigators and federal agencies.

6Research & Development Services
CategoryCore Service
Description

Comprehensive research administration including program development & management, regulatory affairs, research operations, and collaborations & partnerships support. For DoD research sites, federal agencies, and military investigators.

7Government Contracting Services
CategoryCore Service
Description

Contract vehicles, key capabilities, corporate experience & past performance, and partnerships & alliances for federal agencies. Includes GSA Schedule (MAS) for streamlined procurement.

8Data Management
CategoryCore Service
Description

Data management solutions driving innovation and decision making for military medical research programs.

9Staffing Services
CategoryCore Service
Description

Recruiting and managing highly qualified personnel (study coordinators, regulatory specialists, contract personnel) for military research facilities.

Scale indicator11 records

Each record includes

Type, Value, Description, Source

Partnership34 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-03-03
Description

Three-year CRADA with Island Pharmaceuticals and USAMRIID to advance Galidesivir for Marburg Virus Disease under FDA Animal Rule pathway with non-human primate studies toward NDA submission.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Geneva supports USAMRIID researchers including Dr. Kathleen Cashman (Lassa fever vaccine development) and Dr. Sandra Bixler (Marburg virus monoclonal antibody testing). Partnership advancing infectious disease countermeasures for military readiness and global health security.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Geneva serves as teaming partner on $247M U.S. Army Holistic Health and Fitness (H2F) System contract alongside HigherEchelon, Hyperion Biotechnology, and Resolution Think to enhance Soldier readiness and performance.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Long-standing partnership providing expert staffing for the Animal Research Facility enabling biomedical research that improves therapies, rehabilitation, and care standards for veterans.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Cooperative agreement with USU for MIRROR program (musculoskeletal injury research) and 4D Bio3 Center for Biotechnology. Partnership since 2016 MOU expanded in 2017 and 2019 to include TriService Nursing Research Program.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership for medical technology research including Ukraine trauma database project, SurgNow 3D-printed surgical instruments, and other advanced medical technology initiatives.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership for efficacy testing of MBP091 monoclonal antibody against Marburg virus in nonhuman primate model, advancing life-saving countermeasures for highly lethal Marburg virus disease.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Three-year CRADA partnership to advance Galidesivir antiviral for Marburg Virus Disease under FDA Animal Rule pathway, with goal of NDA submission and potential US government procurement and Priority Review Voucher.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partnership co-leading Lassa fever vaccine (LASSARAB) development with $30M NIH grant, using deactivated rabies virus platform demonstrating strong protection in preclinical trials.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic partnership in Lassa fever vaccine research alongside Thomas Jefferson University and USAMRIID, advancing LASSARAB vaccine candidate to Phase 1 clinical trial.

11BARDA
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership through AREVA Network for advanced development of Multiorgan Extracorporeal Life Support (MELS) system, a portable heparin-free ECMO platform.

genevausa.org
Strategic tierMajorTypeTechnology or Integration
Description

AREVA Network partner for extracorporeal life support technology development and integration.

Strategic tierMajorTypeTechnology or Integration
Description

AREVA Network partner for advanced life support technology development.

Strategic tierMajorTypeTechnology or Integration
Description

AREVA Network partner for renal support integration in portable ECMO systems.

Strategic tierMajorTypeTechnology or Integration
Description

AREVA Network partner for life support technology development.

Strategic tierMajorTypeTechnology or Integration
Description

AREVA Network partner for extracorporeal membrane oxygenation technology.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

AREVA Network partner for clinical translation of life support technologies.

Strategic tierMajorTypeTechnology or Integration
Description

AREVA Network partner for integrated life support solutions.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

Partnership for Revite Automated Trauma Resuscitation System (DARPA-funded) and SurgNow 3D-printed surgical instruments (MTEC-funded) for austere environments.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Federal funding partner for multiple research initiatives including musculoskeletal injury studies and warfighter recovery projects.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Federal research partner for Revite trauma system, On-Demand Blood program (derived from Blood Pharming), and GOLDen hour extended EVACuation (GOLDEVAC) efforts.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Federal partner supporting Lassa fever vaccine research ($30M grant) and other biomedical research initiatives.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Federal partner for veteran-focused innovation through VA Puget Sound and other VA facilities supporting animal research and biomedical research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Host site for REC3ON program advancing combat casualty care through research in hemorrhage control, battlefield resuscitation, and innovative treatment technologies.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Federal research partner for blood products and transfusion research including transfusable low-titer Type O whole blood development.

26U.S. Air Force 59th Medical Wing
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Federal partner funding REC3ON research on Negative Pressure Wound Therapy and supporting VAPOR validated assessment program for medical technology readiness.

genevausa.org
27The Henry M. Jackson Foundation for the Advancement of Military Medicine
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Nonprofit partner in the military medical research ecosystem with shared mission to advance military medicine.

genevausa.org
Strategic tierMajorTypeStrategic or Co-development Partner
Description

Academic partner with Dr. Yang Liu for Digital Dental Loupes (Loupes 2.0) project optimizing military dental and maxillofacial care in austere environments.

Strategic tierMajorTypeTechnology or Integration
Description

Industry partner for Loupes 2.0 digital dental loupes development in collaboration with University of Iowa.

Strategic tierMajorTypeStrategic or Co-development Partner
Description

DoD award through AREVA to evaluate SeaStar Medical's SCD therapy for advancing breakthrough burn and sepsis research.

31Armed Forces Research Institute of Medical Sciences (AFRIMS)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

International research site in Bangkok supporting malaria vaccine and infectious disease research with global partners since 2007.

genevausa.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partner with active collaborations across multiple research programs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partner with active collaborations across multiple research programs.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Academic research partner with active collaborations across multiple research programs.

Recent move9 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1The Henry M. Jackson Foundation for the Advancement of Military Medicine
TypeDirect peer
Description

Largest and most direct peer nonprofit supporting military medical research, administering hundreds of millions in DoD research funding with a similar intermediary model connecting military investigators, federal agencies, and industry partners.

TypeDirect peer
Description

Nonprofit scientific research organization performing applied research in defense, health, and CBRNE for government clients; comparable in mission and federal contracting posture, though broader in scope beyond military medicine.

TypeBroad incumbent
Description

Large nonprofit applied science and research organization with substantial defense and biomedical portfolios; operates at significantly greater scale and broader scope but comparable in nonprofit contract research model.

TypeBroad incumbent
Description

Nonprofit research institute performing health, defense, and applied research for government and commercial clients with similar contract and grant administration infrastructure.

TypeDirect peer
Description

Employee-owned research firm providing statistical, health, and clinical research services for federal agencies including HHS and DoD, with comparable government contracting posture.

TypeBroad incumbent
Description

Federally funded research and development center (FFRDC) operator providing research and systems engineering to defense and health agencies; comparable in mission-driven research model though broader in scope.

TypeBroad incumbent
Description

Large federal contractor with a substantial defense health and medical research portfolio, providing technical and program management services to DoD and federal health agencies.

TypeDirect peer
Description

Nonprofit biotech developing vaccines and immune therapies for infectious diseases with significant DoD and global health funding overlap, particularly relevant to Geneva's infectious disease portfolio.

TypeOthers
Description

Nonprofit operating federally funded research and clinical programs with similar C-suite, board, and federal contracting structure, including relationships with DoD and NIH.

10American Type Culture Collection (ATCC)
TypeEmerging player
Description

Nonprofit biological resource and research organization supporting government, academic, and industry research with comparable R&D services and federal sponsor relationships in life sciences.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles20 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Geneva Foundation

Military medical research administrationgenevausa.org

The Geneva Foundation is a 501(c)(3) nonprofit research organization that provides research administration, program management, and contracting services to advance military medical research across 39 DoD installations and federal laboratories, partnering with 250+ government, academic, and industry sponsors.

What The Geneva Foundation does

The Geneva Foundation is a 501(c)(3) nonprofit research organization founded in 1993 and headquartered in Tacoma, Washington, with operational offices in Bethesda, Maryland; Frederick, Maryland; and Fayetteville, North Carolina. The organization provides research administration, regulatory affairs, program management, staffing, and contracting services to support military-relevant medical research across 39 DoD installations, federal laboratories, and academic partner institutions worldwide. Geneva is a statutory nonprofit authorized under the FY2014 National Defense Authorization Act to facilitate partnerships between military investigators and public or private organizations, with the unique ability to proffer or gift intellectual property to the Federal government.

Geneva's core operational model consists of four major research programs: AREVA (wearable life support and trauma technologies), MIRROR (musculoskeletal injury research with 40+ active studies), REC3ON (combat casualty care research), and the USU-4D Bio3 Center for Biotechnology (bioprinting, organ-on-chip, on-demand blood). The organization manages $387M in annual grant funding flowing to Geneva-supported principal investigators and secured over $45M in direct funding in 2024. Geneva partners with 250+ sponsors and collaborators including federal agencies (DoD, NIH, HHS, VA, CDMRP, DARPA, BARDA), academic institutions (Johns Hopkins, Stanford, MIT, Mayo Clinic, Thomas Jefferson), and industry players (Mapp Biopharmaceutical, Island Pharmaceuticals, Maquet Getinge, Fresenius).

Geneva generates revenue through federal research grants and contracts, industry-sponsored clinical trial management, GSA Schedule government contracting services, and donor philanthropy via the Discovery Fund. The organization operates on a break-even nonprofit basis with no profit assessed on grant awards; indirect cost rates are authorized by the Office of Naval Research. Customer concentration is overwhelmingly federal, with the U.S. Department of Defense and Military Health System as the primary client base. Distribution is achieved through embedded personnel at military treatment facilities and federal labs, with the H2F System teaming contract (awarded to Serco Inc. at $247M) representing a major recent commercial channel.

The Geneva Foundation firmographics

Firmographics
Name
The Geneva Foundation
Legal name
The Geneva Foundation
Website
https://genevausa.org
Company type
Private
Founded year
1993
Operating status
Operating
Headcount range
251–500 employees
Short description
The Geneva Foundation is a 501(c)(3) nonprofit research organization that provides research administration, program management, and contracting services to advance military medical research across 39 DoD installations and federal laboratories, partnering with 250+ government, academic, and industry sponsors.
Ownership category
akta.pro rank

The Geneva Foundation industry classification

Industry
Product category
Military medical research administration
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715), Medical Laboratories (621511)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro primary industry
Defense R&D, Test, Evaluation & Innovation (BPAIAHAC)
akta.pro secondary industries
Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM), Research & Science Grantmaking Foundations (BPAGAKAI), Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

Keywords

  • Military medical research
  • Clinical trial administration
  • Federal research contracting
  • Biodefense research
  • Combat casualty care

Where The Geneva Foundation is headquartered

Location

Headquarters

HQ city
Tacoma
HQ country
United States
HQ region
North America

Offices4 records

Markets served

The Geneva Foundation business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Federal Research Grants and Contracts: Geneva secures and manages federal awards from DoD, NIH, HHS, VA, CDMRP, and other agencies. The organization recovers award management expenses through approved indirect cost rates authorized by the Office of Naval Research. Geneva operates on a break-even basis without assessing fees or profit on grant awards.
  2. Industry Sponsorship and Clinical Trial Management: Geneva acts as intermediary between industry sponsors and military physicians, facilitating clinical trials. Military physicians cannot contractually obligate or receive direct payment for clinical trials, so Geneva submits research proposals on their behalf and collaborates with sponsors on agreement terms. Geneva recruits and manages dedicated study coordinators, regulatory specialists, and contract personnel.
  3. Government Contracting: Geneva holds a GSA Schedule under the Multiple Award Schedule (MAS), streamlining federal customer service delivery. Services include staffing, program management, regulatory affairs, and research operations support for federal agencies.
  4. Philanthropy and Donor Contributions: Geneva accepts tax-deductible donations as a 501(c)(3) nonprofit. Donors can contribute to the Discovery Fund to support follow-on research, pilot studies, new researcher empowerment, and urgent challenges.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

The Geneva Foundation product offering

Product offering

Core offering

The Geneva Foundation is a 501(c)(3) nonprofit research organization that administers and manages military medical research on behalf of DoD investigators and federal agencies. It secures and manages federal grants and contracts from DoD, NIH, HHS, VA, and CDMRP; facilitates industry-sponsored clinical trials by acting as the contractual intermediary for military physicians; and deploys dedicated research personnel across 39 DoD installations and federal laboratories. Its program portfolio includes AREVA (critical care/portable ECMO), MIRROR (musculoskeletal injury research), REC3ON (combat casualty care), and the USU-4D Bio3 Center for Biotechnology.

Product overview

The Geneva Foundation is a nonprofit research organization that advances military medical research through multiple specialized programs and service offerings. The core portfolio includes AREVA (critical care and extracorporeal life support technologies), MIRROR (musculoskeletal injury rehabilitation research), REC3ON (combat casualty care research), and the USU-4D Bio3 Center for Biotechnology (bioprinting and advanced biotech). These programs are supported by foundational services including research administration, regulatory affairs, government contracting, data management, staffing, education and training, commercialization support, and research dissemination. The organization operates as a strategic convener connecting government, academia, industry, and research teams to deliver mission-ready medical solutions.

Differentiator

Problem solved

Functional benefit

Brands

  • AREVA (Autonomous Reanimation and Evacuation Research Institute & Innovation Center): Program advancing wearable medical technologies, polytrauma management, and critical care solutions tailored to combat and austere environments.
  • MIRROR (Musculoskeletal Injury Rehabilitation Research for Operational Readiness)
  • REC3ON (Research for Combat Casualty Care Operations Network)
  • Fort Liberty Research Institute
  • 4D Bio3 Center for Biotechnology
  • Wave the Flag Award

Products and services

  • AREVA (Autonomous Reanimation and Evacuation Research Institute & Innovation Center) Research program advancing wearable medical technologies, polytrauma management, and critical care solutions tailored to combat and austere environments; develops portable extracorporeal life support (ECLS/ECMO) systems, heparin-free systems, and autonomous critical care technologies. For military investigators, federal agencies, and industry collaborators.
  • MIRROR (Musculoskeletal Injury Rehabilitation Research for Operational Readiness) Research program providing critical infrastructure and operational support for transforming treatment and preventive care of musculoskeletal injuries (MSKI) within the Military Health System, managing over 40 studies. For military investigators and federal agencies.
  • REC3ON (Research for Combat Casualty Care Operations Network) Research program advancing combat casualty care through research in hemorrhage control, battlefield resuscitation, and innovative treatment technologies. Based at Madigan Army Medical Center with active duty, reservist, and staff surgeons. For military investigators and federal agencies.
  • USU-4D Bio3 Center for Biotechnology Center developing and adapting biotechnology to benefit warfighter readiness and resilience; focuses on biofabrication, tissue engineering, organ-on-chip, on-demand blood production, and bioprinting for austere military environments. For military investigators and federal agencies.
  • Fort Liberty Research Institute Research institute conducting mission-focused research in human performance, sustainment, and traumatic brain injury to support warfighter readiness and resilience. For military investigators and federal agencies.
  • Research & Development Services Comprehensive research administration including program development & management, regulatory affairs, research operations, and collaborations & partnerships support. For DoD research sites, federal agencies, and military investigators.
  • Government Contracting Services Contract vehicles, key capabilities, corporate experience & past performance, and partnerships & alliances for federal agencies. Includes GSA Schedule (MAS) for streamlined procurement.
  • Data Management Data management solutions driving innovation and decision making for military medical research programs.
  • Staffing Services Recruiting and managing highly qualified personnel (study coordinators, regulatory specialists, contract personnel) for military research facilities.

Quantifiable outcome

  • More than 400 research programs supported across military treatment facilities, federal laboratories, and academic institutions worldwide
  • +5 more outcomes

Companies that use The Geneva Foundation

Customer profile

Named customers10 records

Segments5 records

Ideal customer profiles3 records

The Geneva Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature8 records

The Geneva Foundation partnerships and signals

Strategic signal

Partnerships

34 partnerships are on record, tiered core and major.

  • U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)coreStrategic or Co-development Partner · 3 March 2026Three-year CRADA with Island Pharmaceuticals and USAMRIID to advance Galidesivir for Marburg Virus Disease under FDA Animal Rule pathway with non-human primate studies toward NDA submission.
  • U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)coreStrategic or Co-development Partner · 1 January 2024Geneva supports USAMRIID researchers including Dr. Kathleen Cashman (Lassa fever vaccine development) and Dr. Sandra Bixler (Marburg virus monoclonal antibody testing). Partnership advancing infectious disease countermeasures for military readiness and global health security.
  • Serco Inc.coreChannel Partner/ Reseller/ DistributorGeneva serves as teaming partner on $247M U.S. Army Holistic Health and Fitness (H2F) System contract alongside HigherEchelon, Hyperion Biotechnology, and Resolution Think to enhance Soldier readiness and performance.
  • VA Puget Sound Health Care SystemcoreStrategic or Co-development PartnerLong-standing partnership providing expert staffing for the Animal Research Facility enabling biomedical research that improves therapies, rehabilitation, and care standards for veterans.
  • Uniformed Services University (USU)coreStrategic or Co-development PartnerCooperative agreement with USU for MIRROR program (musculoskeletal injury research) and 4D Bio3 Center for Biotechnology. Partnership since 2016 MOU expanded in 2017 and 2019 to include TriService Nursing Research Program.
  • Medical Technology Enterprise Consortium (MTEC)coreStrategic or Co-development PartnerPartnership for medical technology research including Ukraine trauma database project, SurgNow 3D-printed surgical instruments, and other advanced medical technology initiatives.
  • Mapp Biopharmaceutical, Inc.coreStrategic or Co-development PartnerPartnership for efficacy testing of MBP091 monoclonal antibody against Marburg virus in nonhuman primate model, advancing life-saving countermeasures for highly lethal Marburg virus disease.
  • Island PharmaceuticalscoreStrategic or Co-development PartnerThree-year CRADA partnership to advance Galidesivir antiviral for Marburg Virus Disease under FDA Animal Rule pathway, with goal of NDA submission and potential US government procurement and Priority Review Voucher.
  • Thomas Jefferson UniversitycoreStrategic or Co-development PartnerAcademic partnership co-leading Lassa fever vaccine (LASSARAB) development with $30M NIH grant, using deactivated rabies virus platform demonstrating strong protection in preclinical trials.
  • University of Maryland, BaltimorecoreStrategic or Co-development PartnerAcademic partnership in Lassa fever vaccine research alongside Thomas Jefferson University and USAMRIID, advancing LASSARAB vaccine candidate to Phase 1 clinical trial.
  • BARDAcoreStrategic or Co-development PartnerPartnership through AREVA Network for advanced development of Multiorgan Extracorporeal Life Support (MELS) system, a portable heparin-free ECMO platform.
  • DraegermajorTechnology or IntegrationAREVA Network partner for extracorporeal life support technology development and integration.
  • Draper LabsmajorTechnology or IntegrationAREVA Network partner for advanced life support technology development.
  • Fresenius Medical CaremajorTechnology or IntegrationAREVA Network partner for renal support integration in portable ECMO systems.
  • KBR LaboratoriesmajorTechnology or IntegrationAREVA Network partner for life support technology development.
  • Maquet Getinge GroupmajorTechnology or IntegrationAREVA Network partner for extracorporeal membrane oxygenation technology.
  • Mayo CliniccoreStrategic or Co-development PartnerAREVA Network partner for clinical translation of life support technologies.
  • Thornhill MedicalmajorTechnology or IntegrationAREVA Network partner for integrated life support solutions.
  • Critical Innovations, LLCmajorStrategic or Co-development PartnerPartnership for Revite Automated Trauma Resuscitation System (DARPA-funded) and SurgNow 3D-printed surgical instruments (MTEC-funded) for austere environments.
  • Congressionally Directed Medical Research Programs (CDMRP)coreStrategic or Co-development PartnerFederal funding partner for multiple research initiatives including musculoskeletal injury studies and warfighter recovery projects.
  • Defense Advanced Research Projects Agency (DARPA)coreStrategic or Co-development PartnerFederal research partner for Revite trauma system, On-Demand Blood program (derived from Blood Pharming), and GOLDen hour extended EVACuation (GOLDEVAC) efforts.
  • National Institutes of Health (NIH)coreStrategic or Co-development PartnerFederal partner supporting Lassa fever vaccine research ($30M grant) and other biomedical research initiatives.
  • U.S. Department of Veterans Affairs (VA)coreStrategic or Co-development PartnerFederal partner for veteran-focused innovation through VA Puget Sound and other VA facilities supporting animal research and biomedical research.
  • Madigan Army Medical CentercoreStrategic or Co-development PartnerHost site for REC3ON program advancing combat casualty care through research in hemorrhage control, battlefield resuscitation, and innovative treatment technologies.
  • National Heart, Lung, and Blood Institute (NHLBI)coreStrategic or Co-development PartnerFederal research partner for blood products and transfusion research including transfusable low-titer Type O whole blood development.
  • U.S. Air Force 59th Medical WingcoreStrategic or Co-development PartnerFederal partner funding REC3ON research on Negative Pressure Wound Therapy and supporting VAPOR validated assessment program for medical technology readiness.
  • The Henry M. Jackson Foundation for the Advancement of Military MedicinemajorStrategic or Co-development PartnerNonprofit partner in the military medical research ecosystem with shared mission to advance military medicine.
  • University of IowamajorStrategic or Co-development PartnerAcademic partner with Dr. Yang Liu for Digital Dental Loupes (Loupes 2.0) project optimizing military dental and maxillofacial care in austere environments.
  • Unify MedicalmajorTechnology or IntegrationIndustry partner for Loupes 2.0 digital dental loupes development in collaboration with University of Iowa.
  • SeaStar MedicalmajorStrategic or Co-development PartnerDoD award through AREVA to evaluate SeaStar Medical's SCD therapy for advancing breakthrough burn and sepsis research.
  • Armed Forces Research Institute of Medical Sciences (AFRIMS)coreStrategic or Co-development PartnerInternational research site in Bangkok supporting malaria vaccine and infectious disease research with global partners since 2007.
  • Johns Hopkins UniversitycoreStrategic or Co-development PartnerAcademic research partner with active collaborations across multiple research programs.
  • Stanford UniversitycoreStrategic or Co-development PartnerAcademic research partner with active collaborations across multiple research programs.
  • Massachusetts Institute of Technology (MIT)coreStrategic or Co-development PartnerAcademic research partner with active collaborations across multiple research programs.

Scale indicators11 records

Recent moves9 records

Expansion highlights6 records

The Geneva Foundation competitors and assessment

Company assessment

Direct peers

  • The Henry M. Jackson Foundation for the Advancement of Military Medicine: Largest and most direct peer nonprofit supporting military medical research, administering hundreds of millions in DoD research funding with a similar intermediary model connecting military investigators, federal agencies, and industry partners.
  • MRIGlobal: Nonprofit scientific research organization performing applied research in defense, health, and CBRNE for government clients; comparable in mission and federal contracting posture, though broader in scope beyond military medicine.
  • Westat: Employee-owned research firm providing statistical, health, and clinical research services for federal agencies including HHS and DoD, with comparable government contracting posture.
  • Infectious Disease Research Institute (IDRI, now AAHI): Nonprofit biotech developing vaccines and immune therapies for infectious diseases with significant DoD and global health funding overlap, particularly relevant to Geneva's infectious disease portfolio.

Broad incumbents

  • Battelle Memorial Institute: Large nonprofit applied science and research organization with substantial defense and biomedical portfolios; operates at significantly greater scale and broader scope but comparable in nonprofit contract research model.
  • RTI International: Nonprofit research institute performing health, defense, and applied research for government and commercial clients with similar contract and grant administration infrastructure.
  • MITRE Corporation: Federally funded research and development center (FFRDC) operator providing research and systems engineering to defense and health agencies; comparable in mission-driven research model though broader in scope.
  • Science Applications International Corporation (SAIC): Large federal contractor with a substantial defense health and medical research portfolio, providing technical and program management services to DoD and federal health agencies.

Others

Emerging players

  • American Type Culture Collection (ATCC): Nonprofit biological resource and research organization supporting government, academic, and industry research with comparable R&D services and federal sponsor relationships in life sciences.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

The Geneva Foundation social profiles

Digital presence

The Geneva Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Geneva Foundation leadership team

Management profile

Number of profiles

Profiles20 records

The Geneva Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Geneva Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Geneva Foundation

What does The Geneva Foundation do?

The Geneva Foundation is a 501(c)(3) nonprofit research organization that administers and manages military medical research on behalf of DoD investigators and federal agencies. It secures and manages federal grants and contracts from DoD, NIH, HHS, VA, and CDMRP; facilitates industry-sponsored clinical trials by acting as the contractual intermediary for military physicians; and deploys dedicated research personnel across 39 DoD installations and federal laboratories. Its program portfolio includes AREVA (critical care/portable ECMO), MIRROR (musculoskeletal injury research), REC3ON (combat casualty care), and the USU-4D Bio3 Center for Biotechnology.

Is The Geneva Foundation a public or private company?

The Geneva Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was The Geneva Foundation founded?

The Geneva Foundation was founded in 1993. It employs 251 to 500 people.

Where is The Geneva Foundation based?

The Geneva Foundation is headquartered in Tacoma, United States, in the North America region.

How does The Geneva Foundation make money?

Four revenue lines are on record. Federal Research Grants and Contracts are the primary driver. The others are industry Sponsorship and Clinical Trial Management, government Contracting and philanthropy and Donor Contributions.

Who are The Geneva Foundation's main competitors?

Direct peers on record are The Henry M. Jackson Foundation for the Advancement of Military Medicine, MRIGlobal, Westat and Infectious Disease Research Institute (IDRI, now AAHI). Broad incumbents are Battelle Memorial Institute, RTI International, MITRE Corporation and Science Applications International Corporation (SAIC). National Marrow Donor Program / Be The Match is listed as an others. American Type Culture Collection (ATCC) is listed as an emerging player.

Does The Geneva Foundation have an API?

No public API is recorded for The Geneva Foundation.

What industry is The Geneva Foundation in?

The Geneva Foundation's product category is Military medical research administration. Its primary akta.pro industry code is BPAIAHAC, Defense R&D, Test, Evaluation & Innovation, with a secondary code of HLAJAOAM, Global Health Research, Clinical Trials & Product Development Partnerships (PDPs). Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
NewsfileNeuroCatch Inc. Announces Strategic Partnership with The Geneva Foundation to Advance Cognitive Health Research for Military PersonnelNeuroCatch Inc. announced a research partnership with The Geneva Foundation to advance cognitive health research for military personnel. The collaboration will use NeuroCatch's EEG-based platform to assess brain function in about six minutes. The partnership aims to improve cognitive resilience and performance among service members.Small CapsIsland Pharma Partners with USAMRIID and Geneva Foundation for Galidesivir under FDA Animal RuleIsland Pharmaceuticals has entered into a three-year Cooperative Research and Development Agreement (CRADA) with USAMRIID and The Geneva Foundation to advance Galidesivir for Marburg Virus Disease under the FDA Animal Rule pathway, with non-human primate studies planned as key steps toward New Drug Application approval. The collaboration builds on prior FDA alignment confirming the Animal Rule development pathway and follows Island Pharma's recent $9 million placement to fully finance the two-stage development program. The ultimate goal is NDA submission with potential US government procurement and a Priority Review Voucher.GlobeNewswireO2matic’s Autonomous Oxygen Therapy Technology to Be Evaluated in U.S. Prehospital Study Funded by Department of DefenseO2matic ApS, a Copenhagen-based digital health company, announced that its autonomous oxygen titration system will be evaluated in the AURORA Project, a U.S.-based research initiative funded by the Department of Defense ($4.7 million award) and led by the University of Colorado Anschutz School of Medicine. The multi-site clinical trial, conducted through the CU Center for COMBAT Research in collaboration with The Geneva Foundation and U.S. Air Force faculty, aims to assess the technology's ability to reduce cognitive burden on medics, conserve oxygen resources, and improve survival outcomes for military and civilian patients. The study is expected to generate pivotal data to support regulatory approval and broader adoption of autonomous oxygen therapy technologies across both military and civilian healthcare systems.PrwebOREF, MTEC, DOD Select Recipients of $2 Million Research Award CollaborationThe Orthopaedic Research and Education Foundation (OREF), the Medical Technology Enterprise Consortium (MTEC), and the Department of Defense announced recipients of a $2 million research award to accelerate return-to-readiness for service members with musculoskeletal injuries. The Henry Jackson Foundation and the Geneva Foundation were selected to receive $1.3 million and over $700,000 respectively for studies on ACL reconstruction recovery and dynamic knee assessment devices. These research initiatives are scheduled to run from September 2023 through September 2026.Oref$2 Million Research Award AnnouncedThe Orthopaedic Research and Education Foundation (OREF), in collaboration with the Medical Technology Enterprise Consortium (MTEC) and the Department of Defense, announced the selection of recipients for a $2 million research award aimed at accelerating return-to-readiness for military personnel following musculoskeletal injuries. The Henry Jackson Foundation and the Geneva Foundation were selected to receive $1.3 million and over $700,000 respectively for studies on ACL reconstruction rehabilitation and dynamic knee assessment devices. The funding is supported by OREF, which received a gift from The Aircast Foundation, and the remainder is provided by the DOD.GlobeNewswireTFF Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business UpdateTFF Pharmaceuticals reported Q1 2022 financial results and business updates, including a $8.4 million net loss and $26.4 million in cash. The company announced a collaboration with Catalent and a second CRADA with USAMRIID and Geneva Foundation, and initiated Phase 2 trials for inhaled voriconazole and tacrolimus powders.GlobeNewswireTFF Pharmaceuticals Enters into CRADA with the U.S. Army and The Geneva Foundation to Develop Dry Powder Needle-free Medical CountermeasuresTFF Pharmaceuticals entered a CRADA with the U.S. Army's USAMRIID and The Geneva Foundation to evaluate a dry powder SARS-CoV-2 vaccine using its Thin Film Freezing technology. The study will compare intranasal administration to traditional routes, aiming to develop stable, single-dose countermeasures for warfighters.PR NewswirePharm-Olam Selected as a CRO for Department of Defense Support to Operation Warp Speed Vaccine Trials, Partnering with Geneva FoundationPharm-Olam, a global mid-sized clinical research organization, has been selected by the U.S. Department of Defense to support Phase III clinical trials of COVID-19 vaccine candidates under Operation Warp Speed at military treatment facilities. The CRO will provide project management, contract management, and clinical trial site support in partnership with The Geneva Foundation, which specializes in military medical research. The company's chief commercial officer cited its track record of supporting over 50% of new antibiotic approvals by the FDA since 2013 as relevant experience for this vaccine development effort.